Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA 1c reliability
Diabetic Medicine · 2025-07 · 42 (7)
DOI: 10.1111/dme.70011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 27.04.2025. Verfasst von Anxious J Niwaha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UK. Hauptthemen laut MEDLINE: Fructosamine, Glycated Hemoglobin, Serum Albumin, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NIHR Exeter Clinical Research Facility.
Abstract (Originalsprache)
Aims
HbA 1c testing in African populations may be limited due to high prevalence of hemoglobinopathies, anaemia, malaria and renal impairment. We aimed to assess the performance of glycated albumin (GA) and fructosamine in comparison to HbA 1c for determining glycaemic control in Africans living with type 2 diabetes.
Methods
We compared the relationship between fructosamine, GA, and HbA 1c with mean continuous glucose monitoring (CGM) glucose and assessed the impact of sickle cell trait (SCT), anaemia and renal impairment on the relationship between each measure and CGM glucose.
Results
The overall association of HbA 1c , GA and fructosamine with CGM glucose was similar ( r = 0.88 [95%CI: 0.84, 0.91], 0.84 [0.79, 0.88] and 0.84 [0.79, 0.88]), respectively. For detecting those with mean CGM glucose >8 mmol/L HbA 1c had similar diagnostic accuracy to GA and fructosamine, even in those with conditions reported to affect HbA 1c performance ( n = 63). We found no evidence that SCT ( n = 43/192) altered the relationship between HbA 1c , fructosamine or GA with CGM glucose ( p > 0.3 for all). However, individuals with anaemia showed an underestimation of CGM glucose by HbA 1c and fructosamine compared to those without anaemia ( p for interaction
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter Medical School, Exeter, UK.
- Medical Research Council/Uganda Virus Research Institute and LSHTM Uganda Research Unit, Entebbe, Uganda.
- Department of Non-Communicable Diseases Epidemiology, London School of Hygiene and Tropical Medicine (LSHTM), London, UK.
ORCID-Profile: Anxious J Niwaha, Angus G Jones
Förderung
- NIHR Exeter Clinical Research Facility
Zitieren
APA
Niwaha, A. J., Balungi, P. A., McDonald, T. J., Hattersley, A. T., Shields, B. M., Nyirenda, M. J., & Jones, A. G. (2025). Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA 1c reliability. Diabetic Medicine, 42(7). https://doi.org/10.1111/dme.70011
Vancouver
Niwaha AJ, Balungi PA, McDonald TJ, Hattersley AT, Shields BM, Nyirenda MJ, et al. Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA 1c reliability. Diabetic Medicine. 2025;42(7). doi:10.1111/dme.70011
BibTeX
@article{Niwaha2025,
author = {Niwaha, Anxious J and Balungi, Priscilla A and McDonald, Timothy J and Hattersley, Andrew T and Shields, Beverley M and Nyirenda, Moffat J and Jones, Angus G},
title = {Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA 1c reliability},
journal = {Diabetic Medicine},
year = {2025},
volume = {42},
number = {7},
doi = {10.1111/dme.70011}
}
EUVIMED